TO COMPARE THE PLATELET-RICHPLASMA THERAPY AND CORTICOSTEROID INJECTION IN THEMANAGEMENT OF PLANTER FASCIITIS
European Journal of Molecular & Clinical Medicine,
2022, Volume 9, Issue 1, Pages 1620-1626
Abstract
Aim:To compare the platelet-rich plasma therapy and corticosteroid injection in themanagement of planter fasciitis.Methods: The prospective clinical trial was carried out at the Department of Orthopaedics. The research involved 40 patients who were randomly assigned to one of two groups: PRP (n=20) or Steroid (n=20). 25-27 ml of blood was taken from the cubital vein and deposited in a glass tube with 3 ml of citrate dextrose solution to make platelet-rich plasma (ratio 9:1). To avoid clotting, a citrate dextrose solution was utilised. For 10-13 minutes, the blood was centrifuged at 3300 rpm. The top buffy coat yielded 3ml of PRP preparation.
Results: In the steroid and PRP groups, the mean initial or pre injection VAS and AOFAS scores were 8.1±1.9, 60.37±9.58 and 8.9±2.6, 62.57±9.87, respectively, and were similar (0.15 and 0.22). Following injection, the score improved significantly in each group at each follow-up; however, no significant difference could be detected between the two groups at the 1 VAS (4.4±2.5 vs 3.5±0.88), AOFAS (79.89±9.74 vs 81.11±8.74), 3 VAS (2.6±0. 21 VS 2.1±0.78), AOFAS (84.15±10.55 VS 86.99±10.67) and 6-month VAS (2.1±0.85 VS 1.6±0.45, AOFA.
Conclusion: We found that steroid or PRP injection therapy for plantar fasciitis is equally effective.
- Article View: 45
- PDF Download: 92